REVEL: an ensemble method for predicting the pathogenicity of rare missense variants NM Ioannidis, JH Rothstein, V Pejaver, S Middha, SK McDonnell, ... The American Journal of Human Genetics 99 (4), 877-885, 2016 | 2006 | 2016 |
Functional and Evolutionary Insights from the Genomes of Three Parasitoid Nasonia Species JH Werren, S Richards, CA Desjardins, O Niehuis, J Gadau, ... Science 327 (5963), 343-348, 2010 | 938 | 2010 |
Inferring the molecular and phenotypic impact of amino acid variants with MutPred2 V Pejaver, J Urresti, J Lugo-Martinez, KA Pagel, GN Lin, HJ Nam, M Mort, ... Nature communications 11 (1), 5918, 2020 | 580 | 2020 |
Big data in public health: terminology, machine learning, and privacy SJ Mooney, V Pejaver Annual review of public health 39 (1), 95-112, 2018 | 391 | 2018 |
The structural and functional signatures of proteins that undergo multiple events of post‐translational modification V Pejaver, WL Hsu, F Xin, AK Dunker, VN Uversky, P Radivojac Protein Science 23 (8), 1077-1093, 2014 | 367 | 2014 |
Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria V Pejaver, AB Byrne, BJ Feng, KA Pagel, SD Mooney, R Karchin, ... The American Journal of Human Genetics 109 (12), 2163-2177, 2022 | 222 | 2022 |
The comparative genomics and complex population history of Papio baboons J Rogers, M Raveendran, RA Harris, T Mailund, K Leppälä, ... Science Advances 5 (1), eaau6947, 2019 | 149 | 2019 |
When loss-of-function is loss of function: assessing mutational signatures and impact of loss-of-function genetic variants KA Pagel, V Pejaver, GN Lin, HJ Nam, M Mort, DN Cooper, J Sebat, ... Bioinformatics 33 (14), i389-i398, 2017 | 80 | 2017 |
A survey-based analysis of the academic job market JD Fernandes, S Sarabipour, CT Smith, NM Niemi, NM Jadavji, AJ Kozik, ... Elife 9, e54097, 2020 | 63* | 2020 |
Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework G Glusman, PW Rose, A Prlić, J Dougherty, JM Duarte, AS Hoffman, ... Genome medicine 9, 1-10, 2017 | 61 | 2017 |
A predictive tool for identification of SARS-CoV-2 PCR-negative emergency department patients using routine test results RP Joshi, V Pejaver, NE Hammarlund, H Sung, SK Lee, A Furmanchuk, ... Journal of Clinical Virology 129, 104502, 2020 | 60 | 2020 |
Missense variant pathogenicity predictors generalize well across a range of function‐specific prediction challenges V Pejaver, SD Mooney, P Radivojac Human mutation 38 (9), 1092-1108, 2017 | 57 | 2017 |
Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges R Daneshjou, Y Wang, Y Bromberg, S Bovo, PL Martelli, G Babbi, ... Human mutation 38 (9), 1182-1192, 2017 | 49 | 2017 |
SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection S Gombar, T Bergquist, V Pejaver, NE Hammarlund, K Murugesan, ... Diagnostic Microbiology and Infectious Disease 100 (2), 115338, 2021 | 35 | 2021 |
Target site specificity and in vivo complexity of the mammalian arginylome J Wang, VR Pejaver, GP Dann, MY Wolf, M Kellis, Y Huang, BA Garcia, ... Scientific reports 8 (1), 16177, 2018 | 26 | 2018 |
Physicochemical sequence characteristics that influence S-palmitoylation propensity KD Reddy, J Malipeddi, S DeForte, V Pejaver, P Radivojac, VN Uversky, ... Journal of Biomolecular Structure and Dynamics 35 (11), 2337-2350, 2017 | 25 | 2017 |
The loss and gain of functional amino acid residues is a common mechanism causing human inherited disease J Lugo-Martinez, V Pejaver, KA Pagel, S Jain, M Mort, DN Cooper, ... PLoS computational biology 12 (8), e1005091, 2016 | 25 | 2016 |
Recommended practices and ethical considerations for natural language processing‐assisted observational research: a scoping review S Fu, L Wang, S Moon, N Zong, H He, V Pejaver, R Relevo, A Walden, ... Clinical and translational science 16 (3), 398-411, 2023 | 18 | 2023 |
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants MS Cline, G Babbi, S Bonache, Y Cao, R Casadio, X de la Cruz, O Díez, ... Human Mutation 40 (9), 1546-1556, 2019 | 18 | 2019 |
Assessment of methods for predicting the effects of PTEN and TPMT protein variants V Pejaver, G Babbi, R Casadio, L Folkman, P Katsonis, K Kundu, ... Human mutation 40 (9), 1495-1506, 2019 | 18 | 2019 |